High α-lipoic acid-loaded hollow mesoporous prussian blue nanozymes for targeted therapy of nasopharyngeal carcinoma in mice
Journal of Biomaterials Applications · 2025
DOI: 10.1177/08853282251318514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Ya Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, China. Hauptthemen laut MEDLINE: Thioctic Acid, Ferrocyanides, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Research Project of Hainan Provincial Health Industry.
Abstract (Originalsprache)
This study successfully constructs a tumor-targeting α-lipoic acid-loaded hollow mesoporous prussian blue nanozyme (AHPRzyme) for targeted therapy of nasopharyngeal carcinoma in mice. In these nanozymes, Arg-Gly-Asp (RGD) acts as a targeting ligand, enabling effective targeting of tumor cells. Additionally, AHPRzyme exhibits multiple anti-tumor mechanisms: ① The prussian blue nanozymes in AHPRzyme have catalase (CAT) activity, which decomposes H 2 O 2 in human nasopharyngeal carcinoma CEN2 cells into non-toxic H 2 O, reducing H 2 O 2 levels and minimizing damage to normal cells. The released O 2 helps alleviate the hypoxic environment of the tumor, inhibiting lactate production due to hypoxia and consequently suppressing tumor growth. ② The prussian blue nanozymes also have peroxidase (POD) activity, which catalyzes H 2 O 2 in tumor cells to generate ·OH, a reactive oxygen species, leading to tumor cell apoptosis. ③ The α-lipoic acid structure in AHPRzyme contains disulfide bonds that react with GSH, depleting excess glutathione (GSH) in tumor cells, disrupting the oxidative stress balance within the cells, and making them more sensitive to reactive oxygen species, thereby increasing tumor cell apoptosis. In summary, AHPRzyme can inhibit tumor cell growth and promote tumor cell apoptosis by improving the tumor microenvironment, achieving the goal of anti-nasopharyngeal carcinoma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
ORCID-Profile: Yuxia Zou
Förderung
- Research Project of Hainan Provincial Health Industry
Zitieren
APA
Pan, Y., Wang, X., Zhou, X., Chen, H., & Zou, Y. (2025). High α-lipoic acid-loaded hollow mesoporous prussian blue nanozymes for targeted therapy of nasopharyngeal carcinoma in mice. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251318514
Vancouver
Pan Y, Wang X, Zhou X, Chen H, Zou Y. High α-lipoic acid-loaded hollow mesoporous prussian blue nanozymes for targeted therapy of nasopharyngeal carcinoma in mice. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251318514
BibTeX
@article{Pan2025,
author = {Pan, Ya and Wang, Xiaofeng and Zhou, Xuejun and Chen, Haipeng and Zou, Yuxia},
title = {High α-lipoic acid-loaded hollow mesoporous prussian blue nanozymes for targeted therapy of nasopharyngeal carcinoma in mice},
journal = {Journal of Biomaterials Applications},
year = {2025},
doi = {10.1177/08853282251318514}
}
EUVIMED